期刊文献+

不同剂量TP方案化疗联合同步放疗治疗局部晚期食管癌的疗效观察 被引量:5

Different doses of TP regimen combined and concurrent radiotherapy to the treatment of locally advanced esophageal cancer
下载PDF
导出
摘要 目的探讨不同剂量TP方案化疗联合同步放疗治疗局部晚期食管癌疗效及毒副反应。方法 53例局部晚期食管癌患者分成三组:大剂量紫杉醇+顺铂联合放疗组(以下简称大剂量组:DDP100mg/m2,dl;PTX175mg/m2,d1)18例;小剂量紫杉醇+顺铂联合放疗组(以下简称小剂量组:DDP20mg/m2,dl-5;PTX20mg/m2,dl、3、5)16例;单纯放疗组19例。化疗21天为1个周期;放疗采用三维适形放疗,常规分割,总剂量60Gy/6W。结果大剂量组、小剂量组、单纯放疗组完全缓解(CR)率、有效率(CR+PR)及1年生存率分别为58.8%、81.3%、26.3%;88.2%、93.8%、57.9%及94.1%、100%、73.7%。三组比较,大、小剂量组CR率、CR+PR率均较单纯放疗组有统计学差异,P〈0.05;小剂量组与单纯放疗组在1年生存率上差异有统计学意义,P〈0.05。毒副反应大剂量组在骨髓抑制、胃肠道反应、脱发,较小剂量组、单纯放疗组差异有统计学意义,P〈0.05。结论小剂量TP方案化疗联合同步放疗治疗局部晚期食管癌,疗效较好,毒副反应可以耐受。 Objective To investigate different dose of TP regimen of concurrent radiotherapy and chemotherapy combined treatment of locally advanced esophageal cancer efficacy and toxicity. Methods 53 patients with locally advanced esophageal cancer patients were divided into three groups : High doses of paclitaxel plus cisplatin in combination with radiotherapy group( hereinafter referred to as the high dose group:the DDP 100 mg/m2 dl ;PTX175 mg/m2, dl )18 cases; Low doses of paclitaxel plus cisplatin combination with radiotherapy group (hereinafter referred to as Low doses Group:DDP 20 mg/m2 dl -5 ;of PTX 20 mg/m2 dl ,3,5 )16 cases; 19 cases of the radiotherapy alone group. Chemotherapy 21 days for a cycle;Radiotherapy using three - dimensional eonformal radiotherapy, conventional fractionation, total dose 60 Gy/6 W. Results The high - dose group, low - ose group, radiotherapy group, complete remission ( CR ) rate, response rate ( CR + PR ) and 1 - year survival rates were 58.8%,81.3%,26.3%;88.2%,93.8%,57.9 % and 94. 1%,100%,73.7%,respectirely. Three groups,high and low dose group, CR rate, CR + PR rate than radiotherapy alone group were significantly different ( P 〈 0.05 ) ; low - dose group and radiotherapy group in the 1 - year survival difference was statistically significant, P 〈 0.05. The toxicity of high - dose group in the bone marrow suppression, gastrointestinal reactions, hair loss, the lower dose group and radiotherapy group difference was statistically significant ( P 〈 0.05 ). Conclusion Small doses of TP chemotherapy with concurrent radiotherapy and the treatment of locally advanced esophageal cancer hare better efficacy,and its toxicity can be tolerated.
出处 《实用肿瘤学杂志》 CAS 2012年第3期241-245,共5页 Practical Oncology Journal
关键词 食管肿瘤 不同剂量 同期放化疗 Esophageal neoplasms Different doses Concurrent chemo - radiotherapy
  • 相关文献

参考文献10

二级参考文献117

共引文献132

同被引文献58

  • 1廖思海,韩雪萍,谢忠,杨志雄.三维适形放疗结合奥沙利铂为主的化疗治疗晚期直肠癌[J].中华放射肿瘤学杂志,2007,16(5):356-358. 被引量:11
  • 2Stahl, Michael, Lehmann, et al. Prediction of prognosis afterchemodaltherapy in patients with locally advanced squamous cellcarcinoma of the oesophagus[J]. European journal of cancer,2012,48(16):2977-2982.
  • 3Pasini, Felice; de Manzoni, Giovanni; Zanoni, Neoadjuvant therapywith weekly docetaxel and cisplatin, 5-fluorouracil continuousinfusion, and concurrent radiotherapy in patients with locallyadvanced esophageal cancer produced a high percentage oflong-lasting pathological complete response: A phase 2 study [J].Cancer,2013,119(19):939-945.
  • 4Schena, Marina, La Rovere, et al. Neoadjuvant chemo-radiotherapy forlocally advanced esophageal cancer: a monocentric study [J]. Tumori,2012,98(4):451-457.
  • 5钟连花,刘健,陈俊强.食管癌术后辅助放化疗的临床研究[J],中囯医药导报,2010,7(7): 11-12.
  • 6Zhao Kuai-le, Hu Xi-chun. A phase I dose escalation study ofNimotuzumab in combination with concurrent chemoradia- tion forpatients with locally advanced squamous cell carcinoma of esophagus[J]. Investigational new drugs,2012,30(4): 1585-1590.
  • 7Bharat, Ankit, Crabtree, Traves. Management of advanced-stageoperable esophageal cancerfJ]. The Surgical clinics of North America,2012,92(5):1179-1197.
  • 8Papp Andras, Cseke Laszlo, Varga Gabor. The role of neoadjuvanttherapy in the treatment of locally advanced squamous cell cancer ofthe cervical oesophagus[J]. Magyar sebeszet,2012,65(5):340-347.
  • 9Lin JC, Jan JS, Hsu CY, et al. Phase 111 study of concurrent chemoradiotherapy versus radiotherapy alone for advanced naso- pharyngeal carcinoma: positive effect on overall and progression- free survival[J]. J Clin Oncol, 2003, 21 (4) :631 -637.
  • 10Mehta M, Scrimger R, Mackkie R, et al. A new approach to dose escalation in non-small-cel| lung cancer[ J]. Int J Radiat Oncol Biol Phys, 2001, 49( 1 ) :23 -33.

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部